D
Kalaris Therapeutics, Inc. KLRS
$5.54 $0.071.28% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2025 06/30/2025 09/30/2024
Total Cash And Short-Term Investments -12.92% -12.42% --
Total Receivables -- -- --
Inventory -- -- --
Prepaid Expenses -63.29% 165.00% --
Finance Division Loans and Leases Current -- -- --
Total Finance Division Other Current Assets -- -- --
Other Current Assets -- -- --
Total Current Assets -14.69% -10.31% --

Total Current Assets -14.69% -10.31% --
Net Property, Plant & Equipment -- -- --
Long-term Investments -- -- --
Goodwill -- -- --
Total Other Intangibles -- -- --
Finance Div Loans & Leases LT -- -- --
Total Finance Div Other LT Assets -- -- --
Total Other Assets 23.93% 30.88% --
Total Assets -12.57% -9.94% --

Total Accounts Payable -86.58% 55.01% --
Total Accrued Expenses 35.68% -15.62% --
Short-term Debt -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- --
Finance Division Debt Current -- -- --
Total Finance Division Other Current Liabilities -- -38.26% --
Total Other Current Liabilities -- -38.26% --
Total Current Liabilities -20.73% 7.13% --

Total Current Liabilities -20.73% 7.13% --
Long-Term Debt -- -- --
Short-term Debt -- -- --
Capital Leases -- -- --
Finance Division Debt Non Current -- -- --
Total Finance Division Other Non Current Liabilities -- -- --
Total Other Liabilities 0.00% 0.00% --
Total Liabilities -1.05% 1.30% --

Common Stock & APIC 0.33% 0.31% --
Retained Earnings -8.61% -8.95% --
Treasury Stock & Other -- -- --
Total Common Equity -21.18% -16.84% --

Preferred Stock Redeemable -- -- --
Preferred Stock Non Redeemable -- -- --
Preferred Stock Convertible -- -- --
Preferred Stock, Others -- -- --
Total Preferred Equity -- -- --

Total Common Equity -21.18% -16.84% --
Total Preferred Equity -- -- --
Total Minority Interest -- -- --
Total Equity -21.18% -16.84% --